Nexthera Capital’s Immunomedics Inc IMMU Stock Holding History

Nexthera Capital’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$7.27M	Buy	524,140 +189,416	+57%	+$2.85M	6.06%	7
2019 Q1	$6.43M	Sell	334,724 -559,955	-63%	-$9.03M	7.8%	4
2018 Q4	$12.8M	Sell	894,679 -503,898	-36%	-$10M	5.26%	7
2018 Q3	$29.1M	Buy	1,398,577 +69,473	+5%	+$1.65M	5.58%	4
2018 Q2	$31.5M	Buy	1,329,104 +247,694	+23%	+$4.98M	4.87%	3
2018 Q1	$15.8M	Buy	1,081,410 +676,882	+167%	+$11.1M	2.6%	10
2017 Q4	$6.54M	Sell	404,528 -387,578	-49%	-$4.57M	1.21%	25
2017 Q3	$11.1M	Buy	+792,106	New	+$7.89M	2.85%	9
2016 Q4	–	Sell	-1,263,276	Closed	-$4.11M	–	50
2016 Q3	$4.11M	Buy	+1,263,276	New	+$3.53M	2.52%	13

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Nexthera Capital's IMMU Position: Q2 2019 in Review

Nexthera Capital increased its Immunomedics Inc (IMMU) stake by 57% in Q2 2019, buying an estimated $2.85M and bringing the position to 524,140 shares worth $7.27M. The position accounts for 6.06% of the portfolio, ranked #7.

Nexthera Capital first reported a position in IMMU in Q3 2016 and has held it in 9 quarters since. The position peaked at $31.5M in Q2 2018. 204 funds tracked by Wall St. Rank hold IMMU as of Q2 2019.

Nexthera Capital held 524,140 shares of Immunomedics Inc worth $7.27M as of Q2 2019.
Nexthera Capital bought 189,416 Immunomedics Inc shares in Q2 2019, an estimated $2.85M.
Immunomedics Inc made up 6.06% of Nexthera Capital's portfolio in Q2 2019, its #7 holding.
Nexthera Capital first reported a position in Immunomedics Inc in Q3 2016 and has held it in 9 quarters since.
Nexthera Capital's Immunomedics Inc position peaked at $31.5M in Q2 2018.
204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.